NCBJ And JAEA To Boost Research And Development In HTGRs On November 22, in Tokyo, the President of the Japanese Atomic Energy Agency (JAEA), Mr. Koguchi Masanori and the Director of the Polish National Centre for Nuclear Research (NCBJ), Prof. Krzysztof Kurek signed an Implementing Arrangement regarding the institution’s cooperation in research and development in…
Wales Unveils Plans For Its New Nuclear Medicine Facility The Welsh Government has recently unveiled its major plans for the new national nuclear medicine laboratory, which aims at making Wales a global centre of excellence and the leading location for medical radioisotope production in the UK. The Project ARTHUR (Advanced Radioisotope Technology for Health Utility Reactor)…
Urenco Stable Isotopes Joins UNRANU Research Programme Urenco (ENS Corporate Member) Stable Isotopes recently joined the Understanding the Radiobiology of therapeutic medical radionuclides (UNRANU) programme as a consortium partner. The UNRANU programme is developing new production routes for radionuclides; finding the best match between radionuclide and tumour type, determining the optimal treatment dose, and investigating…
Mo-99 Ready To Be Produced At Darlington NPP The Darlington Nuclear Power Plant, located in Canada and operated by Ontario Power Generation (OPG), is now ready to produce life-saving Molybdenum-99 (Mo-99) isotopes, Laurentis Energy Partners and BWXT Medical Ltd announced last week. Thanks to the installation and initial commissioning of an innovative isotope system made…
SCK CEN And IRE Starts The Construction Of RECUMO Facility SCK CEN (ENS Corporate Member) and IRE – Institut National des Radioéléments inaugurated the construction of the RECUMO facility. The joint project represents the structural solution for the management of all of the highly radioactive residues stored at the IRE’s site in Fleurus (Belgium) which…
“What can I do to help improve patients’ lives?” Interview with Katya Popova, Researcher at the Institute for Nuclear Research and Nuclear Energy, Sofia Exciting recent developments in nuclear medicine provide effective cancer treatment in an ever more targeted way with minimal side effects. Today we talk with Katya Popova, Ph.D. in Genetics, and working…
NRG And TerThera Cooperate To Secure Terbium-161 Supply Last week, NRG (ENS Corporate Member) and TerThera signed an agreement for irradiation services in the High Flux Reactor in Petten to produce Terbium-161. The non-carrier-added (NCA) Terbium-161 is produced by neutron irradiation of highly enriched Gadolinium-160 targets in the Dutch research reactor. Terbium-161 is a promising novel…
“Nuclear medicine has a great unexplored potential” Interview with Anthony Waked, PhD Fellow at SCK CEN – Belgian Nuclear Research Centre and the University of Liège, Belgium In the past decade, research has made tremendous progress and medical isotopes are expected to become a vital tool in the treatment of many types of cancers in…
SCK CEN Announced A New Partnership To Accelerate The Fight Against Cancer The Belgian Nuclear Research Centre SCK CEN (ENS Corporate Member) announced that the US-based SpectronRx will open its first European radiolabeling facility for sorely needed medical radioisotopes. The facility will be established on the premises of the research centre in Mol, Belgium. Both…
SCK CEN And TerThera Collaborate To Secure Terbium-161 Supply SCK CEN (ENS Corporate Member) and TerThera signed an agreement to handle together the production process of Terbium-161, a promising novel radionuclide for cancer treatment. Terbium-161 can meet the growing demand in cancer healthcare, exhibiting comparable (radio)chemical characteristics to known radiolanthanides. Targeted cancer therapies with Terbium-161 are expected…